二十年间强直性脊柱炎发病率、患病率及诊断时间的变化
基于英国临床实践研究数据链的全科医生数据,识别1998至2017年确诊强直性脊柱炎(AS)患者12333例,评估年发病率、患病率及从首次背痛症状至风湿科转诊和诊断的时间变化。结果显示发病率1998至2007年显著下降后于2017年回升,患病率持续上升,从首次症状至诊断的中位时间由1998年的3.62年延长至2017年的8.31年,女性延迟更长。
要点
- AS发病率从1998年每万患者年0.72降至2007年0.39(仅男性显著),2017年回升至0.57。
- AS患病率从1998年0.13%升至2017年0.18%,女性和≥60岁患者上升更陡。
- 从首次症状至风湿科转诊中位时间4.87年,至诊断中位时间从3.62年延长至8.31年,女性更长。
核心结论
- AS发病率在1998至2007年间显著下降,2007至2017年间上升,可能反映对AS识别或诊断信心的改善,源于对炎性背痛和早期治疗重要性的认识提高。
- AS患病率上升可能提示患者生存改善;风湿科转诊和诊断的持续延迟仍令人担忧,尤其是女性。
研究设计与样本
- 使用英国临床实践研究数据链(Clinical Practice Research Datalink)的全科医生数据,识别1998至2017年确诊AS的患者12333例。
- 估计年AS发病率、患病率以及从首次记录的背痛症状至风湿科转诊和诊断的时间长度。
主要发现
- 共识别12333例AS患者。
- AS发病率从1998年的0.72(±0.14)/10000患者年降至2007年的0.39(±0.06),该下降仅在男性中显著,随后至2017年回升至0.57(±0.11)。
- AS患病率从1998年的0.13%±0.006升至2017年的0.18%±0.006,女性从0.06%±0.05升至0.10%±0.06,≥60岁患者从0.14%±0.01升至0.26%±0.01。
- 从首次症状至风湿科转诊的总体中位时间为4.87年(IQR=1.42-10.23)。
- 从首次症状至诊断的中位时间从1998年的3.62年(IQR=1.14-7.07)升至2017年的8.31年(IQR=3.77-15.89),女性为6.71年(IQR=2.30-12.36),长于男性的5.65年(IQR=1.66-11.20)。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
OBJECTIVES: To assess changes in ankylosing spondylitis (AS) incidence, prevalence and time to diagnosis, between 1998 and 2017. METHODS: Using UK GP data from the Clinical Practice Research Datalink, we identified patients diagnosed with AS between 1998 and 2017. We estimated the annual AS incidence, prevalence and length of time from first recorded symptom of back pain to rheumatology referral and diagnosis. RESULTS: We identified 12 333 patients with AS. The incidence declined from 0.72 (±0.14) per 10 000 patient-years in 1998 to 0.39 (±0.06) in 2007, with this decline significant only in men, then incidence rose to 0.57 (±0.11) in 2017. By contrast, prevalence increased between 1998 and 2017 (from 0.13%±0.006 to 0.18%±0.006), rising steeply among women (from 0.06%±0.05 to 0.10%±0.06) and patients aged ≥60 (from 0.14%±0.01 to 0.26%±0.01). The overall median time from first symptom to rheumatology referral was 4.87 years (IQR=1.42-10.23). The median time from first symptom to diagnosis rose between 1998 and 2017 (from 3.62 years (IQR=1.14-7.07) to 8.31 (IQR=3.77-15.89)) and was longer in women (6.71 (IQR=2.30-12.36)) than men (5.65 (IQR=1.66-11.20)). CONCLUSION: AS incidence declined significantly between 1998 and 2007, with an increase between 2007 and 2017 that may be explained by an improvement in the recognition of AS or confidence in diagnosing AS over time, stemming from increased awareness of inflammatory back pain and the importance of early treatment. The rising AS prevalence may indicate improved patient survival. The persisting delay in rheumatology referral and diagnosis remains of concern, particularly in women.
引用
- Crossfield SSR, Marzo-Ortega H, Kingsbury SR, et al. Changes in ankylosing spondylitis incidence, prevalence and time to diagnosis over two decades. RMD Open. 2021. PMID: 34887345. doi:10.1136/rmdopen-2021-001888
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。